Kiran Kumar Rathinam

Employment

Employment history is unavailable.

Education

• SRM College of Pharmacy Pharm.D (Doctor of Pharmacy)
  2016 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Pharmacist led intervention towards management of type 2 diabetes mellitus and assessment of patient satisfaction of care - A prospective, randomized controlled study.
  Manithottiyle Angelo Simon, Bandaru Yeswanth Raja, Paulin C. Varughese

  +6 more

  • Linda Mary Daniel
  • Kolli Sowjanya
  • Kumar J. S
  • S. Sarumathy
  • Kiran Kumar Rathinam
  • +1 more
  Diabetes & metabolic syndrome 2021 DOI: 10.1016/j.dsx.2021.102208
  +Save
• Role of fluoxetine in pharmacological enhancement of motor functions in stroke patients: A randomized, placebo-controlled, single-blind trial.
  Karthickeyan Krishnan, K Muthuraj, K Nandhini

  +4 more

  • Yalamanchili Dharma Teja
  • Vikrama Simha Reddy
  • Neethu Sara Raju
  • Kiran Kumar Rathinam
  Contemporary clinical trials communications 2021 DOI: 10.1016/j.conctc.2021.100800
  +Save
• Therapeutic Potential of Ferric maltol in the Treatment of Iron deficiency anemia: An Evidence-Based Review
  International Journal of Pharmaceutical Research 2021 DOI: 10.31838/ijpr/2021.13.02.444
  +Save
• Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia—A Prospective, Interventional, Pilot Study
  Nanditha Rajesh, L. Drishya, Murali Mohan Raju Ambati

  +5 more

  • Athi L. Narayanan
  • Maria Alex
  • Kiran Kumar Rathinam
  • Justin Jacob Abraham
  • T Vijayakumar
  Journal of Clinical and Experimental Hepatology 2021 DOI: 10.1016/j.jceh.2021.03.012
  +Save
• Phenytoin Induced Stevens Johnson Syndrome- Toxic Epidermal Necrolysis Overlap Exacerbated by Cephalexin in a 65-Year-Old Neurosurgical Patient: A Rare Case Report.
  Vijayakumar Thangavel Mahalingam, Kiran Kumar Rathinam, Sarvesh Sabarathinam +1 more
  Current drug research reviews 2021 DOI: 10.2174/2589977513666210322160009
  +Save
• Siltuximab - A monoclonal antibody against the interleukin-6 receptor is not an ideal option for management of COVID-19
  I Jerlin Michelle, S. A. Shevaani, Kiran Kumar Rathinam

  +3 more

  • Justin Jacob Abraham
  • Muhasaparur Ganesan Rajanandh
  • Thangavel Mahalingam Vijayakumar
  Current Medicine Research and Practice 2021 DOI: 10.4103/cmrp.cmrp_28_20
  +Save
• Progression of Type-2 Diabetes Mellitus Associated with Pulmonary Tuberculosis Sequelae in a 60 Year Old Hypertensive Patient: A Multifactorial Case Report with Literature Review
  Poojith Nuthalapati, Kiran Kumar Rathinam, Sarvesh Sabarathinam
  Acta Scientific Pharmaceutical Sciences 2020 DOI: 10.31080/asps.2020.04.0590
  +Save
• Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review
  Kiran Kumar Rathinam, Justin Jacob Abraham, Thangavel Mahalingam Vijayakumar
  Current Therapeutic Research 2019 DOI: 10.1016/j.curtheres.2019.100571
  +Save
• A CASE STUDY ON SCHIZOPHRENIA INDUCED MULTIPLE COMORBIDITIES
  M Jagadeesan, Kiran Kumar Rathinam, Justin Jacob Abraham
  Asian Journal of Pharmaceutical and Clinical Research 2018 DOI: 10.22159/ajpcr.2018.v11i6.23979
  +Save